News May 13, 2026
Revenue grew approximately 35% year-over-year to $15.5 million for Q1 2026 Net income increased by over...
News April 29, 2026
BURLINGTON, Mass. and JERUSALEM, Israel, April 29, 2026 — BrainsWay Ltd. (NASDAQ & TASE: BWAY)...
News April 15, 2026
Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access...
News March 26, 2026
BURLINGTON, Mass. and JERUSALEM, Israel, March 26, 2026 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...
News March 19, 2026
BrainsWay’s investment is part of its ongoing strategy to partner with leading U.S. mental health providers...
News March 11, 2026
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights Q4 Revenue...
News March 4, 2026
BURLINGTON, Mass. and JERUSALEM, March 4, 2026 — BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled...
News February 17, 2026
Change in ADS ratio aimed at simplifying comparisons to ordinary shares traded on the Tel Aviv Stock...
News January 12, 2026
BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home...
News December 22, 2025
New Premera Blue Cross policy extends to both adolescent and adult depression patients BURLINGTON, Mass....
News November 25, 2025
BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...
Events, News November 21, 2025
Deep TMS™ becomes first and only TMS device cleared in treatment of patients ages 15 to 86 suffering...
News November 20, 2025
Multicenter, randomized, controlled study will evaluate Company’s next-generation multichannel TMS...
News November 1, 2026
Revenue increased 29% to $13.5 million in Q3 2025 as compared with Q3 2024 Operating income totaled...
News October 27, 2025
Recent agreements with two additional U.S. mental health providers bring total to four in 2025 Strategy...
News October 28, 2025
BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...
News September 16, 2025
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard...
News August 21, 2025
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be...
